Home NDC 0169-6432-10 Levemir
Product NDC 0169-6432
Requested package NDC 0169-6432-10
11-digit product format 001696432
Labeler code 0169
Product ID 0169-6432_40c85e9f-5e3e-4f53-a642-1ee982273108
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name insulin detemir
Dosage form INJECTION, SOLUTION
Route SUBCUTANEOUS
Labeler Novo Nordisk
Application BLA021536
Marketing category BLA
Marketing start 2013-10-31
Marketing end 0000-00-00
Substance INSULIN DETEMIR
Active strength 100 [iU]/mL
Pharmacologic classes Insulin Analog [EPC], Insulin [Chemical/Ingredient]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0169-6432-10 Levemir 5 in 1 CARTON INJECTION, SOLUTION 5 30 0169-6432-55 Levemir 3 mL in 1 SYRINGE, PLASTIC INJECTION, SOLUTION 3 30
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded INSULIN DETEMIR ACTIVE INGREDIENT 4FT78T86XV LEVEMIR (INSULIN DETEMIR) INJECTION, SOLUTION [NOVO NORDISK] 15 INSULIN DETEMIR ACTIVE MOIETY 4FT78T86XV LEVEMIR (INSULIN DETEMIR) INJECTION, SOLUTION [NOVO NORDISK] 15 GLYCERIN INACTIVE INGREDIENT PDC6A3C0OX LEVEMIR (INSULIN DETEMIR) INJECTION, SOLUTION [NOVO NORDISK] 15 HYDROCHLORIC ACID INACTIVE INGREDIENT QTT17582CB LEVEMIR (INSULIN DETEMIR) INJECTION, SOLUTION [NOVO NORDISK] 15 METACRESOL INACTIVE INGREDIENT GGO4Y809LO LEVEMIR (INSULIN DETEMIR) INJECTION, SOLUTION [NOVO NORDISK] 15 PHENOL INACTIVE INGREDIENT 339NCG44TV LEVEMIR (INSULIN DETEMIR) INJECTION, SOLUTION [NOVO NORDISK] 15 SODIUM CHLORIDE INACTIVE INGREDIENT 451W47IQ8X LEVEMIR (INSULIN DETEMIR) INJECTION, SOLUTION [NOVO NORDISK] 15 SODIUM HYDROXIDE INACTIVE INGREDIENT 55X04QC32I LEVEMIR (INSULIN DETEMIR) INJECTION, SOLUTION [NOVO NORDISK] 15 SODIUM PHOSPHATE, DIBASIC, DIHYDRATE INACTIVE INGREDIENT 94255I6E2T LEVEMIR (INSULIN DETEMIR) INJECTION, SOLUTION [NOVO NORDISK] 15 ZINC INACTIVE INGREDIENT J41CSQ7QDS LEVEMIR (INSULIN DETEMIR) INJECTION, SOLUTION [NOVO NORDISK] 15
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0169-6432 LEVEMIR (INSULIN DETEMIR) INJECTION, SOLUTION [NOVO NORDISK] 28 Legacy NDC, 2 package rows 20240605_d38d65c1-25bf-401d-9c7e-a2c3222da8af.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Levemir INSULIN DETEMIR A-S Medication Solutions 82192527-99aa-4b53-8ce9-9173668d309c 2024-10-09 Warnings, Adverse reactions Exact identifier application number: BLA021536
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 021536 Levemir insulin detemir 351(a) Disc 2026-09-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 0169-6432-10 00169643210 5 SYRINGE, PLASTIC in 1 CARTON (0169-6432-10) > 3 mL in 1 SYRINGE, PLASTIC (0169-6432-55) 2022-12-02 0000-00-00 No No Current